Researchers at Karolinska Institutet in Sweden have managed to sequence the giant genome of a salamander, the Iberian ribbed newt, which is a full six times greater than the human genome.
Amongst the early findings is a family of genes that can provide clues to the unique ability of salamanders to rebuild complex tissue, even body parts. The study is published in Nature Communications.
This is the first time that an entire newt genome has been sequenced, an achievement that can give rise to new discoveries on the amphibian’s ability to recreate brain neurons as well as entire body parts. Amongst the first findings are a multitude of copies of a certain microRNA group, which in mammals is mainly found in embryonic stem cells, but also in tumour cells.
“It will be exciting to figure out how regeneration in the adult organism re-activates embryonic genes,” says study leader Professor András Simon at Karolinska Institutet’s Department of Cell and Molecular Biology. “What’s needed now are functional studies of these microRNA molecules to understand their function in regeneration. The link to cancer cells is also very interesting, especially bearing in mind newts’ marked resistance to tumour formation.”
Even though the abundance of stem cell microRNA genes is quite surprising, it alone cannot explain how salamanders regenerate so well. Professor Simon predicts that the explanation lies in a combination of genes unique to salamanders and how other more common genes orchestrate and control the actual regeneration process.
One of the reasons why salamander genomes have not been sequenced before is its sheer size – six times bigger than the human genome in the case of the Iberian newt, which has posed an enormous technical and methodological challenge.
“It’s only now that the technology is available to handle such a large genome,” says Professor Simon. “The sequencing per se doesn’t take that long – it’s recreating the genome from the sequences that’s so time consuming.”
“We all realised how challenging it was going to be,” recounts first author Ahmed Elewa, postdoctoral fellow at the same department. “But the very fact that it was such a challenge made it all the more exciting.”
The group at Karolinska Institutet is now engaging with other researchers to discover what can be learned from the newt genome and test new hypotheses through systematic comparisons with mammals.
“We showed ten years ago that salamanders can recreate all the cells that die in Parkinson’s disease in the space of four weeks,” says Professor Simon. “We can now delve deeply into the molecular processes underlying this ability. Although we’re doing basic research, our findings can hopefully lead to the development of new regenerative strategies for humans.”
The Latest on: Regenerative medicine
- BRIEF-China Regenerative Medicine International Proposes To Raise Between About Hk$351.72 Mln & Hk$354.23 Mlnon November 28, 2019 at 4:02 pm
Nov 28 (Reuters) - China Regenerative Medicine International Ltd: * PROPOSES TO RAISE NOT LESS THAN HK$351.72 MILLION & NOT MORE THAN ABOUT HK$354.23 MILLION BY ISSUING OFFER SHARES * TO ISSUE BETWEEN ...
- Regenerative Medicine Market: Facts, Figures and Analytical Insights 2019-2024on November 28, 2019 at 1:48 am
Nov 28, 2019 (AmericaNewsHour) -- As stated by the research report published by Azoth Analytics in August 2019, the Global Regenerative Medicine Market was valued at USD 22,814.45 million the year ...
- Hitachi develops automation technology of 3D culture to expand regenerative medicine businesson November 27, 2019 at 9:29 pm
Furthermore the support service to establish an automatic manufacturing process for customers who are considering automation of manufacturing regenerative medicine products will be started on December ...
- Global Regenerative Medicine Market Analysis 2018-2019 with Forecasts to 2025 - ResearchAndMarkets.comon November 27, 2019 at 4:30 pm
The "Regenerative Medicine Market Size, Outlook and Growth Opportunities, 2019- 2025" report has been added to ResearchAndMarkets.com's offering. This report includes the latest predictions of the ...
- Hitachi Developed Automation Technology of 3D Culture to Expand Regenerative Medicine Businesson November 26, 2019 at 8:17 pm
A schematic diagram of automated new 3D culture*10 Furthermore the support service to establish an automatic manufacturing process for customers who are considering automation of manufacturing ...
- Regenerative Medicine Market Trends, Drivers, Strategies, Size, Demand, Growth, Applications and Competitive Landscape 2024on November 26, 2019 at 12:36 am
Nov 26, 2019 (The Expresswire) -- Regenerative Medicine Market 2019 Global Industry research report offers you market size, industry growth, share, development trends, product demand, investment plans ...
- AVITA Medical and the Gates Center for Regenerative Medicine at the University of Colorado Anschutz ...on November 24, 2019 at 2:45 pm
AVITA Medical (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, and scientists at the ...
- Heartseed Raises $26M in Series B Funding to Accelerate Development of iPSC-derived Regenerative Medicine for Heart Failureon November 22, 2019 at 4:00 am
which has supported Heartseed from Series A. “I have been involved in the research of cardiac regenerative medicine for the past 20-years as a pioneer in this field and solved all the major challenges ...
- MEDIA ADVISORY: Advances in Regenerative Medicine through Exosome Therapy presented by Dr. Ducan Ross, founder of Kimera Labs at Perpetual Lifeon November 21, 2019 at 5:43 am
As a pioneer in the development of cell-free exosome products, Dr. Ross's research has been and continues to be employed by many physicians and clinics in a variety of regenerative medicine protocols.
- Did You Manage To Avoid China Regenerative Medicine International's (HKG:8158) 96% Share Price Wipe Out?on November 19, 2019 at 7:49 pm
Over the last month the China Regenerative Medicine International Limited (HKG:8158) has been much stronger than before, rebounding by 135%. But the last three years have seen a terrible decline.
via Google News and Bing News